Skip to main content
Inpatient Procedure Code

XW04388

Introduction of Treosulfan into Central Vein, Percutaneous Approach, New Technology Group 8

Introduce Treosulfan in Central Vein, Perc, New Tech 8

Axis Breakdown

Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.

PositionValueMeaning
1
SectionX

New Technology

2
Body SystemW

Anatomical Regions

3
Root Operation0

Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4
Body Part4

Central Vein

5
Approach3

Percutaneous

6
Device / Substance / Technology8

Treosulfan

7
New Technology Group8

New Technology Group 8

Related Codes

Same operation — other Body Part

Same table and root operation, differing only in the body part character.

XW03388 — Introduction of Treosulfan into Peripheral Vein, Percutaneous Approach, New Technology Group 8

Same operation — other Device / Substance / Technology

Same table and root operation, differing only in the device / substance / technology character.

XW04308 — Introduction of Spesolimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 8, XW04358 — Introduction of Mosunetuzumab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 8, XW04368 — Introduction of Afamitresgene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 8, XW04378 — Introduction of Tabelecleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 8, XW04398 — Introduction of Inebilizumab-cdon into Central Vein, Percutaneous Approach, New Technology Group 8

Same operation — other Qualifier

Same table and root operation, differing only in the qualifier character.

XW04387 — Introduction of Lurbinectedin into Central Vein, Percutaneous Approach, New Technology Group 7, XW0438A — Introduction of Obecabtagene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 10

Contextual Map

Every relationship of XW04388 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

PCS table

  • XW0[PCS table]
  • [object Object] — Section: [object Object] [Section]: “[object Object]”
  • [object Object] — Body System: [object Object] [Body System]: “[object Object]”
  • [object Object] — Operation: [object Object] [Operation]: “[object Object]”

Nearest codes

  • XW03388 — Introduction of Treosulfan into Peripheral Vein, Percutaneous Approach, New Technology Group 8 [One axis away]
  • XW04308 — Introduction of Spesolimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 8 [One axis away]
  • XW04358 — Introduction of Mosunetuzumab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 8 [One axis away]
  • XW04368 — Introduction of Afamitresgene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 8 [One axis away]
  • XW04378 — Introduction of Tabelecleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 8 [One axis away]
  • XW04387 — Introduction of Lurbinectedin into Central Vein, Percutaneous Approach, New Technology Group 7 [One axis away]
  • XW0438A — Introduction of Obecabtagene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 10 [One axis away]
  • XW04398 — Introduction of Inebilizumab-cdon into Central Vein, Percutaneous Approach, New Technology Group 8 [One axis away]

Change history

No changes recorded for this code — unchanged since the FY2026 (April) baseline of the change ledger.